The use of maoto (Ma-Huang-Tang), a traditional Japanese Kampo medicine, to alleviate flu symptoms: a systematic review and meta-analysis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Tetsuhiro Yoshino, Ryutaro Arita, Yuko Horiba, Kenji Watanabe

ABSTRACT

BACKGROUND: Influenza is a common viral infection worldwide. Maoto (ma-huang-tang) was developed in ancient China and is used to alleviate flu symptoms. Currently, no meta-analyses have evaluated the efficacy and safety of maoto for alleviating flu symptoms. METHODS: In the present study, we searched MEDLINE/PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, a Japanese database (Ichushi), two Chinese databases (China National Knowledge Infrastructure and VIP), and two Korean databases (Korean Medical database and Korean Association of Medical Journal Editors) for studies published in or before October 2017. Clinical studies that compared maoto plus neuraminidase inhibitors (NAIs) vs. NAIs alone, or maoto alone vs. NAIs alone, were included in the present analysis. The primary outcome measure (efficacy) was the length of time from the start of medication to resolution of influenza symptoms (fever, headache, malaise, myalgia, and chills) and virus isolation. The secondary outcome measures (safety) were as follows: (1) side effects and adverse reactions, such as nausea, abnormal behaviour, or discontinuation of symptomatic treatment; (2) morbidity (complications caused by influenza infection) or mortality; and (3) hospitalisation for any reason. RESULTS: Twelve relevant studies were identified, including two randomised controlled trials (RCTs, N = 60) and ten non-randomised studies (NRSs, N = 1110). We found that maoto plus NAIs was superior to NAIs alone in terms of the duration of fever in one RCT (P < 0.05, median difference = - 6 h) and four NRSs (P = 0.003, weighted mean difference = - 5.34 h). The duration of symptoms or virus isolation did not differ between maoto and NAIs. No severe side effects or adverse reactions were reported related to maoto or NAIs. CONCLUSIONS: Although we could not reach a definitive conclusion because of the small sample sizes and high risk of bias in the analysed studies, maoto may lower the duration of fever when it is used alone or in combination with NAIs and may be a well-tolerated treatment. More RCTs are needed to determine the efficacy and safety of maoto. More... »

PAGES

68

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12906-019-2474-z

DOI

http://dx.doi.org/10.1186/s12906-019-2474-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112856128

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30885188


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drugs, Chinese Herbal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Medicine, Kampo", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Oregon State University", 
          "id": "https://www.grid.ac/institutes/grid.4391.f", 
          "name": [
            "Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan", 
            "Linus Pauling Institute, Oregon State University, Linus Pauling Science Center, Corvallis, OR, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshino", 
        "givenName": "Tetsuhiro", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tohoku University", 
          "id": "https://www.grid.ac/institutes/grid.69566.3a", 
          "name": [
            "Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan", 
            "Department of Education and Support for Regional Medicine, Department of Kampo Medicine, Tohoku University School of Medicine, 1-1 Seiryo, Aoba-ku, Sendai, Miyagi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arita", 
        "givenName": "Ryutaro", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Keio University", 
          "id": "https://www.grid.ac/institutes/grid.26091.3c", 
          "name": [
            "Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horiba", 
        "givenName": "Yuko", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Keio University", 
          "id": "https://www.grid.ac/institutes/grid.26091.3c", 
          "name": [
            "Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan", 
            "Faculty of Environment and Information Studies, Keio University, 5322 Endo, Fujisawa, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Watanabe", 
        "givenName": "Kenji", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1159/000341547", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005288372"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.antiviral.2007.01.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008518945"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3143/geriatrics.44.31", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014216330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1590/1516-3180.20141324t2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019004739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.phymed.2006.09.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024267375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4236/health.2011.35052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024324310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.transproceed.2012.03.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025228439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/infdis/jiq012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029730812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.i4919", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031711389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.i4919", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031711389"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd004559.pub4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037112181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0166-3542(99)00067-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037765092"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/tkm2.1027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040896760"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2014/187036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046129421"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10156-012-0378-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046627210", 
          "https://doi.org/10.1007/s10156-012-0378-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.antiviral.2009.04.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050866501"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/14787210.2015.981156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068079163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-155-4-201108160-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073712388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/tkm2.1064", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083749138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2017/1062065", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091294580"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41540-017-0032-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092277074", 
          "https://doi.org/10.1038/s41540-017-0032-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.antiviral.2018.07.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105260262"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1716197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106678691"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1716197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106678691"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Influenza is a common viral infection worldwide. Maoto (ma-huang-tang) was developed in ancient China and is used to alleviate flu symptoms. Currently, no meta-analyses have evaluated the efficacy and safety of maoto for alleviating flu symptoms.\nMETHODS: In the present study, we searched MEDLINE/PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, a Japanese database (Ichushi), two Chinese databases (China National Knowledge Infrastructure and VIP), and two Korean databases (Korean Medical database and Korean Association of Medical Journal Editors) for studies published in or before October 2017. Clinical studies that compared maoto plus neuraminidase inhibitors (NAIs) vs. NAIs alone, or maoto alone vs. NAIs alone, were included in the present analysis. The primary outcome measure (efficacy) was the length of time from the start of medication to resolution of influenza symptoms (fever, headache, malaise, myalgia, and chills) and virus isolation. The secondary outcome measures (safety) were as follows: (1) side effects and adverse reactions, such as nausea, abnormal behaviour, or discontinuation of symptomatic treatment; (2) morbidity (complications caused by influenza infection) or mortality; and (3) hospitalisation for any reason.\nRESULTS: Twelve relevant studies were identified, including two randomised controlled trials (RCTs, N\u00a0=\u200960) and ten non-randomised studies (NRSs, N\u00a0=\u20091110). We found that maoto plus NAIs was superior to NAIs alone in terms of the duration of fever in one RCT (P\u00a0<\u20090.05, median difference\u2009=\u2009-\u20096\u2009h) and four NRSs (P\u00a0=\u20090.003, weighted mean difference\u2009=\u2009-\u20095.34\u2009h). The duration of symptoms or virus isolation did not differ between maoto and NAIs. No severe side effects or adverse reactions were reported related to maoto or NAIs.\nCONCLUSIONS: Although we could not reach a definitive conclusion because of the small sample sizes and high risk of bias in the analysed studies, maoto may lower the duration of fever when it is used alone or in combination with NAIs and may be a well-tolerated treatment. More RCTs are needed to determine the efficacy and safety of maoto.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12906-019-2474-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1028418", 
        "issn": [
          "1472-6882"
        ], 
        "name": "BMC Complementary and Alternative Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "The use of maoto (Ma-Huang-Tang), a traditional Japanese Kampo medicine, to alleviate flu symptoms: a systematic review and meta-analysis", 
    "pagination": "68", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b00eb087d6901ba8b6e90e92ab8e99c80ce935bf438dbe369838693ce0fa0033"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30885188"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101088661"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12906-019-2474-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112856128"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12906-019-2474-z", 
      "https://app.dimensions.ai/details/publication/pub.1112856128"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130831_00000006.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12906-019-2474-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2474-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2474-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2474-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12906-019-2474-z'


 

This table displays all metadata directly associated to this object as RDF triples.

182 TRIPLES      21 PREDICATES      56 URIs      26 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12906-019-2474-z schema:about N46ff72e8c71547da9987686f6dd6cf3c
2 N808bb246a1f74100ac6d9f0fc4736e95
3 N9fea8205fd394688b199c67a14df7ea8
4 Nca1fe0aaf9e942f5990a8bc0bf24861b
5 Nf4e0cabf968b473baa70430c9d72afab
6 anzsrc-for:11
7 anzsrc-for:1103
8 schema:author N6f270efb28774da88a1b81246d7cdf4b
9 schema:citation sg:pub.10.1007/s10156-012-0378-7
10 sg:pub.10.1038/s41540-017-0032-1
11 https://doi.org/10.1002/14651858.cd004559.pub4
12 https://doi.org/10.1002/tkm2.1027
13 https://doi.org/10.1002/tkm2.1064
14 https://doi.org/10.1016/j.antiviral.2007.01.003
15 https://doi.org/10.1016/j.antiviral.2009.04.012
16 https://doi.org/10.1016/j.antiviral.2018.07.001
17 https://doi.org/10.1016/j.phymed.2006.09.015
18 https://doi.org/10.1016/j.transproceed.2012.03.003
19 https://doi.org/10.1016/s0166-3542(99)00067-4
20 https://doi.org/10.1056/nejmoa1716197
21 https://doi.org/10.1093/infdis/jiq012
22 https://doi.org/10.1136/bmj.i4919
23 https://doi.org/10.1155/2014/187036
24 https://doi.org/10.1155/2017/1062065
25 https://doi.org/10.1159/000341547
26 https://doi.org/10.1586/14787210.2015.981156
27 https://doi.org/10.1590/1516-3180.20141324t2
28 https://doi.org/10.3143/geriatrics.44.31
29 https://doi.org/10.4236/health.2011.35052
30 https://doi.org/10.7326/0003-4819-155-4-201108160-00005
31 schema:datePublished 2019-12
32 schema:datePublishedReg 2019-12-01
33 schema:description BACKGROUND: Influenza is a common viral infection worldwide. Maoto (ma-huang-tang) was developed in ancient China and is used to alleviate flu symptoms. Currently, no meta-analyses have evaluated the efficacy and safety of maoto for alleviating flu symptoms. METHODS: In the present study, we searched MEDLINE/PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, a Japanese database (Ichushi), two Chinese databases (China National Knowledge Infrastructure and VIP), and two Korean databases (Korean Medical database and Korean Association of Medical Journal Editors) for studies published in or before October 2017. Clinical studies that compared maoto plus neuraminidase inhibitors (NAIs) vs. NAIs alone, or maoto alone vs. NAIs alone, were included in the present analysis. The primary outcome measure (efficacy) was the length of time from the start of medication to resolution of influenza symptoms (fever, headache, malaise, myalgia, and chills) and virus isolation. The secondary outcome measures (safety) were as follows: (1) side effects and adverse reactions, such as nausea, abnormal behaviour, or discontinuation of symptomatic treatment; (2) morbidity (complications caused by influenza infection) or mortality; and (3) hospitalisation for any reason. RESULTS: Twelve relevant studies were identified, including two randomised controlled trials (RCTs, N = 60) and ten non-randomised studies (NRSs, N = 1110). We found that maoto plus NAIs was superior to NAIs alone in terms of the duration of fever in one RCT (P < 0.05, median difference = - 6 h) and four NRSs (P = 0.003, weighted mean difference = - 5.34 h). The duration of symptoms or virus isolation did not differ between maoto and NAIs. No severe side effects or adverse reactions were reported related to maoto or NAIs. CONCLUSIONS: Although we could not reach a definitive conclusion because of the small sample sizes and high risk of bias in the analysed studies, maoto may lower the duration of fever when it is used alone or in combination with NAIs and may be a well-tolerated treatment. More RCTs are needed to determine the efficacy and safety of maoto.
34 schema:genre research_article
35 schema:inLanguage en
36 schema:isAccessibleForFree true
37 schema:isPartOf N94dd83b46e834078b27b2586da1585fe
38 Nf5b6337220404109a2b49ebf86e7f62e
39 sg:journal.1028418
40 schema:name The use of maoto (Ma-Huang-Tang), a traditional Japanese Kampo medicine, to alleviate flu symptoms: a systematic review and meta-analysis
41 schema:pagination 68
42 schema:productId N1668616509e8496a978455de009253b6
43 N27add1976e6c4621b9088d459ff17290
44 N426a8e2356b443aaa925d41cd4224dde
45 N51315e11987c4923a25b277f2454b575
46 Ne5706dceed1b46adbab1f5225642f5a8
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112856128
48 https://doi.org/10.1186/s12906-019-2474-z
49 schema:sdDatePublished 2019-04-11T14:03
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher Ndd01ce3607174555a048ec6f776bae49
52 schema:url https://link.springer.com/10.1186%2Fs12906-019-2474-z
53 sgo:license sg:explorer/license/
54 sgo:sdDataset articles
55 rdf:type schema:ScholarlyArticle
56 N0a4ee13da076426089ea7fe6ffc4e499 rdf:first N6cf183c427a6409d86c8d8612337a739
57 rdf:rest rdf:nil
58 N1668616509e8496a978455de009253b6 schema:name readcube_id
59 schema:value b00eb087d6901ba8b6e90e92ab8e99c80ce935bf438dbe369838693ce0fa0033
60 rdf:type schema:PropertyValue
61 N1849fda2027342ea8753efade34c30c8 rdf:first N3983f8bc390e45deaf23ab309d303e95
62 rdf:rest N0a4ee13da076426089ea7fe6ffc4e499
63 N21c072c4ce2c4433bbb998058c118f6f schema:affiliation https://www.grid.ac/institutes/grid.69566.3a
64 schema:familyName Arita
65 schema:givenName Ryutaro
66 rdf:type schema:Person
67 N27add1976e6c4621b9088d459ff17290 schema:name nlm_unique_id
68 schema:value 101088661
69 rdf:type schema:PropertyValue
70 N3983f8bc390e45deaf23ab309d303e95 schema:affiliation https://www.grid.ac/institutes/grid.26091.3c
71 schema:familyName Horiba
72 schema:givenName Yuko
73 rdf:type schema:Person
74 N426a8e2356b443aaa925d41cd4224dde schema:name pubmed_id
75 schema:value 30885188
76 rdf:type schema:PropertyValue
77 N434ab1de4b0a47c39cfc5bb1cd5e7f50 rdf:first N21c072c4ce2c4433bbb998058c118f6f
78 rdf:rest N1849fda2027342ea8753efade34c30c8
79 N46ff72e8c71547da9987686f6dd6cf3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Influenza, Human
81 rdf:type schema:DefinedTerm
82 N51315e11987c4923a25b277f2454b575 schema:name doi
83 schema:value 10.1186/s12906-019-2474-z
84 rdf:type schema:PropertyValue
85 N6cf183c427a6409d86c8d8612337a739 schema:affiliation https://www.grid.ac/institutes/grid.26091.3c
86 schema:familyName Watanabe
87 schema:givenName Kenji
88 rdf:type schema:Person
89 N6f270efb28774da88a1b81246d7cdf4b rdf:first Nf694fe0128af4868af4e945876be3b72
90 rdf:rest N434ab1de4b0a47c39cfc5bb1cd5e7f50
91 N808bb246a1f74100ac6d9f0fc4736e95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Antiviral Agents
93 rdf:type schema:DefinedTerm
94 N94dd83b46e834078b27b2586da1585fe schema:issueNumber 1
95 rdf:type schema:PublicationIssue
96 N9fea8205fd394688b199c67a14df7ea8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Humans
98 rdf:type schema:DefinedTerm
99 Nca1fe0aaf9e942f5990a8bc0bf24861b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Medicine, Kampo
101 rdf:type schema:DefinedTerm
102 Ndd01ce3607174555a048ec6f776bae49 schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 Ne5706dceed1b46adbab1f5225642f5a8 schema:name dimensions_id
105 schema:value pub.1112856128
106 rdf:type schema:PropertyValue
107 Nf4e0cabf968b473baa70430c9d72afab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Drugs, Chinese Herbal
109 rdf:type schema:DefinedTerm
110 Nf5b6337220404109a2b49ebf86e7f62e schema:volumeNumber 19
111 rdf:type schema:PublicationVolume
112 Nf694fe0128af4868af4e945876be3b72 schema:affiliation https://www.grid.ac/institutes/grid.4391.f
113 schema:familyName Yoshino
114 schema:givenName Tetsuhiro
115 rdf:type schema:Person
116 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
117 schema:name Medical and Health Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
120 schema:name Clinical Sciences
121 rdf:type schema:DefinedTerm
122 sg:journal.1028418 schema:issn 1472-6882
123 schema:name BMC Complementary and Alternative Medicine
124 rdf:type schema:Periodical
125 sg:pub.10.1007/s10156-012-0378-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046627210
126 https://doi.org/10.1007/s10156-012-0378-7
127 rdf:type schema:CreativeWork
128 sg:pub.10.1038/s41540-017-0032-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092277074
129 https://doi.org/10.1038/s41540-017-0032-1
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1002/14651858.cd004559.pub4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037112181
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1002/tkm2.1027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040896760
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1002/tkm2.1064 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083749138
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1016/j.antiviral.2007.01.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008518945
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1016/j.antiviral.2009.04.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050866501
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1016/j.antiviral.2018.07.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105260262
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/j.phymed.2006.09.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024267375
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/j.transproceed.2012.03.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025228439
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1016/s0166-3542(99)00067-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037765092
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1056/nejmoa1716197 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106678691
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1093/infdis/jiq012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029730812
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1136/bmj.i4919 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031711389
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1155/2014/187036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046129421
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1155/2017/1062065 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091294580
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1159/000341547 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005288372
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1586/14787210.2015.981156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068079163
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1590/1516-3180.20141324t2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019004739
164 rdf:type schema:CreativeWork
165 https://doi.org/10.3143/geriatrics.44.31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014216330
166 rdf:type schema:CreativeWork
167 https://doi.org/10.4236/health.2011.35052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024324310
168 rdf:type schema:CreativeWork
169 https://doi.org/10.7326/0003-4819-155-4-201108160-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073712388
170 rdf:type schema:CreativeWork
171 https://www.grid.ac/institutes/grid.26091.3c schema:alternateName Keio University
172 schema:name Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan
173 Faculty of Environment and Information Studies, Keio University, 5322 Endo, Fujisawa, Kanagawa, Japan
174 rdf:type schema:Organization
175 https://www.grid.ac/institutes/grid.4391.f schema:alternateName Oregon State University
176 schema:name Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan
177 Linus Pauling Institute, Oregon State University, Linus Pauling Science Center, Corvallis, OR, USA
178 rdf:type schema:Organization
179 https://www.grid.ac/institutes/grid.69566.3a schema:alternateName Tohoku University
180 schema:name Center for Kampo Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan
181 Department of Education and Support for Regional Medicine, Department of Kampo Medicine, Tohoku University School of Medicine, 1-1 Seiryo, Aoba-ku, Sendai, Miyagi, Japan
182 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...